Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis

Pancreatic cancer is one of the cancer types with poor prognosis and high rate of mortality. Diagnostic modalities for early detection of pancreatic cancer have been among the academic concerns. On account of the potential role of immunohistochemistry (IHC) biomarkers in overcoming certain limitatio...

Descripción completa

Detalles Bibliográficos
Autor principal: Luu, Tuan Trong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720928/
https://www.ncbi.nlm.nih.gov/pubmed/34988027
http://dx.doi.org/10.3389/fonc.2021.799025
_version_ 1784625230130446336
author Luu, Tuan Trong
author_facet Luu, Tuan Trong
author_sort Luu, Tuan Trong
collection PubMed
description Pancreatic cancer is one of the cancer types with poor prognosis and high rate of mortality. Diagnostic modalities for early detection of pancreatic cancer have been among the academic concerns. On account of the potential role of immunohistochemistry (IHC) biomarkers in overcoming certain limitations of imaging diagnostic tools in discriminating pancreatic cancer tissues from benign ones, a growing scholarly attention has been given to the diagnostic efficacy of IHC biomarkers for pancreatic cancer. This review will analyze and synthesize published articles to provide an insight into potential IHC biomarkers for pancreatic cancer diagnosis.
format Online
Article
Text
id pubmed-8720928
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87209282022-01-04 Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis Luu, Tuan Trong Front Oncol Oncology Pancreatic cancer is one of the cancer types with poor prognosis and high rate of mortality. Diagnostic modalities for early detection of pancreatic cancer have been among the academic concerns. On account of the potential role of immunohistochemistry (IHC) biomarkers in overcoming certain limitations of imaging diagnostic tools in discriminating pancreatic cancer tissues from benign ones, a growing scholarly attention has been given to the diagnostic efficacy of IHC biomarkers for pancreatic cancer. This review will analyze and synthesize published articles to provide an insight into potential IHC biomarkers for pancreatic cancer diagnosis. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8720928/ /pubmed/34988027 http://dx.doi.org/10.3389/fonc.2021.799025 Text en Copyright © 2021 Luu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Luu, Tuan Trong
Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title_full Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title_fullStr Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title_full_unstemmed Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title_short Review of Immunohistochemistry Biomarkers in Pancreatic Cancer Diagnosis
title_sort review of immunohistochemistry biomarkers in pancreatic cancer diagnosis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720928/
https://www.ncbi.nlm.nih.gov/pubmed/34988027
http://dx.doi.org/10.3389/fonc.2021.799025
work_keys_str_mv AT luutuantrong reviewofimmunohistochemistrybiomarkersinpancreaticcancerdiagnosis

Ejemplares similares